汇添富创新医药混合A(006113)资产负债表
|
2025-06-30 |
2024-12-31 |
2024-06-30 |
2023-12-31 |
资产 |
银行存款 |
- |
- |
- |
- |
结算备付金 |
73,772,499.67 |
20,209,901.60 |
8,164,578.27 |
5,866,122.17 |
存出保证金 |
1,039,059.90 |
795,858.61 |
859,915.07 |
1,163,880.30 |
交易性金融资产 |
8,591,205,314.84 |
4,179,710,569.73 |
4,155,385,569.90 |
6,409,224,579.11 |
其中:股票投资 |
8,589,995,135.36 |
3,915,643,369.23 |
3,954,033,766.62 |
5,874,045,109.18 |
债券投资 |
1,210,179.48 |
264,067,200.50 |
201,351,803.28 |
535,179,469.93 |
资产支持证券投资 |
- |
- |
- |
- |
衍生金融资产 |
- |
- |
- |
- |
买入返售金融资产 |
- |
228,195,924.02 |
- |
- |
应收证券清算款 |
- |
26,872,263.35 |
100,322,179.77 |
13,667,067.64 |
应收利息 |
- |
- |
- |
- |
应收股利 |
2,755,647.72 |
- |
2,425,912.16 |
- |
应收申购款 |
53,738,381.11 |
809,190.21 |
1,320,305.85 |
2,391,796.44 |
其他资产 |
- |
- |
- |
- |
资产总计 |
9,492,521,616.36 |
4,686,353,134.86 |
4,993,222,222.68 |
6,784,141,064.60 |
负 债 |
短期借款 |
- |
- |
- |
- |
交易性金融负债 |
- |
- |
- |
- |
衍生金融负债 |
- |
- |
- |
- |
卖出回购金融资产款 |
- |
- |
- |
- |
应付证券清算款 |
197,983,181.97 |
- |
20,331,430.83 |
- |
应付赎回款 |
3,516,369.64 |
2,910,893.70 |
1,975,645.54 |
3,021,077.25 |
应付管理人报酬 |
8,701,414.82 |
5,025,551.63 |
5,115,681.56 |
6,887,663.87 |
应付托管费 |
1,450,235.81 |
837,591.95 |
852,613.58 |
1,147,943.98 |
应付销售服务费 |
437,020.42 |
- |
- |
- |
应付交易费用 |
- |
- |
- |
- |
应交税费 |
- |
- |
- |
- |
应付利息 |
- |
- |
- |
- |
应付利润 |
- |
- |
- |
- |
其他负债 |
4,697,941.57 |
2,228,762.88 |
3,342,271.87 |
2,286,802.02 |
负债合计 |
216,786,164.23 |
11,002,800.16 |
31,617,643.38 |
13,343,487.12 |
所有者权益 |
实收基金 |
5,589,504,744.65 |
3,727,146,732.53 |
4,010,522,075.42 |
4,250,683,618.46 |
未分配利润 |
3,686,230,707.48 |
948,203,602.17 |
951,082,503.88 |
2,520,113,959.02 |
所有者权益合计 |
9,275,735,452.13 |
4,675,350,334.70 |
4,961,604,579.30 |
6,770,797,577.48 |
负债及所有者权益总计 |
9,492,521,616.36 |
4,686,353,134.86 |
4,993,222,222.68 |
6,784,141,064.60 |
欢迎访问证券之星!请点此与我们联系 版权所有: Copyright © 1996-年